A globally-renowned prostate cancer surgeon shares the latest advancements in the field and stresses the importance of early ...

A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." IF YOU’VE NEVER had a prostate cancer screening, you may worry that it will be embarrassing and ...

Adding the drug enzalutamide to standard hormone therapy reduced deaths by more than 40% in men with recurrent prostate ...

Eric Morrow had a family history of prostate cancer, but because he was not yet 55, they wouldn't screen him. However, a ...

Junkins, who specializes in internal medicine, diligently monitored his health, including annual prostate-specific antigen checks, which consistently came back normal. “I’ve checked my PSAs and all my ...

A powerful new drug combination—niraparib added to standard prostate cancer therapy—has been shown to significantly delay ...

Dr. Wallen: When the prostate cancer is only in the prostate and hasn't spread elsewhere, the standard of care treatments are ...

High profile politicians have thrown their weight behind calls to screen at-risk men for prostate cancer, but are potential ...

Today' anchor Al Roker was first diagnosed after bloodwork at a routine checkup showed elevated prostate specific antigen ...

Doctors are “overtesting” men for prostate cancer and not targeting “those most likely to benefit,” researchers have warned. Prostate cancer is the most commonly diagnosed cancer in the UK, affecting ...